WallStSmart
SYBX

Synlogic Inc

NASDAQ: SYBX · HEALTHCARE · BIOTECHNOLOGY

$0.64
+0.00% today

Updated 2026-06-04

Market cap
$7.72M
P/E ratio
P/S ratio
936.86x
EPS (TTM)
$-0.06
Dividend yield
52W range
$1 – $2
Volume
0.0M

WallStSmart proprietary scores

27
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D
6.0
Quality
B
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$1.00
+56.25%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-563000.00
- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$1.18M$3.37M$8000.00$0.00$0.00
Net income$-66.15M$-57.28M$-23.36M$-1.00M$681000.00
EPS$-0.06
Free cash flow$-57.62M$-51.83M$-31.67M$-4.36M$-563000.00
Profit margin-5,605.68%-1,699.26%-291,987.50%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SYBX$7.72M273.73.05.06.0Avoid
LLY$948.95B7810.010.05.06.0Strong Buy
JNJ$536.54B594.79.03.36.0-71.41%Buy
ABBV$380.57B634.08.04.05.0-55.64%Buy
UNH$343.21B545.35.54.75.5-26.61%Buy
MRK$285.64B503.38.02.75.0-49.34%Hold

Smart narrative

Synlogic Inc trades at $0.64. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Synlogic Inc's stock price?

Synlogic Inc (SYBX) trades at $0.64, on a P/S of 936.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Synlogic Inc overvalued?

Synlogic Inc carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Synlogic Inc (SYBX)?

The 12-month analyst consensus target is $1.00, about 56.3% above the current $0.64. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio936.86x
ROE-5.11%
Beta0.52
50D MA$0.64
200D MA$1.10
Shares out0.01B
Float0.00B
Short ratio
Avg volume0.0M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years